Table 1.
Baseline Characteristics of LTx From January 1, 2003, to December 31, 2005, by Donor Race
| Donor race |
|||||
|---|---|---|---|---|---|
| Caucasian N = 7631 |
AA N = 1579 |
API N = 243 |
Other N = 1421 |
P | |
| Donor | |||||
| Mean age, y (SD) | 42.9 (17.8) | 40.8 (17.0) | 45.2 (17.6) | 37.4 (16.9) | <.01 |
| Female | 3295 (43.2%) | 659 (41.7%) | 119 (49.0%) | 465 (32.7%) | <.01 |
| Cause of death (reference, head trauma) | |||||
| Anoxia | 984 (12.9%) | 165 (10.5%) | 30 (12.3%) | 151 (10.6%) | .01 |
| Cerebrovascular accident | 3391 (44.4%) | 855 (54.2%) | 144 (59.3%) | 581 (40.9%) | <.01 |
| HBc positive | 246 (3.2%) | 185 (11.8%) | 70 (28.8%) | 79 (5.6%) | <.01 |
| Mean height, cm (SD) | 172.4 (10.6) | 172.1 (11.5) | 164.0 (10.3) | 168.2 (10.4) | <.01 |
| Mean difference in recipient–donor height, cm (SD) | 0.2 (13.2) | 0.4 (13.9) | 5.7 (13.7) | 2.8 (13.3) | <.01 |
| Recipient | |||||
| Mean age, y (SD) | 52.6 (9.5) | 52.4 (9.5) | 53.3 (10.0) | 52.3 (9.8) | .24 |
| Diagnosis | |||||
| Hepatitis C | 3387 (44.4) | 710 (45.0%) | 119 (49.0%) | 674 (47.4%) | .11 |
| Hepatitis B | 239 (3.1%) | 66 (4.2%) | 21 (8.6%) | 53 (3.7%) | <.01 |
| Alcoholic liver disease | 1227 (16.1) | 255 (16.1%) | 32 (13.2%) | 250 (17.6%) | .29 |
| MELD score at transplant (SD) | 20.6 (8.6) | 20.2 (8.5) | 20.3 (9.3) | 22.3 (9.5) | <.01 |
| Public insurance | 1776 (23.3%) | 358 (22.7%) | 55 (22.6%) | 293 (20.6%) | .18 |
| Median creatinine level, mg/dL (IQR) | 1.1 (0.8–1.6) | 1.0 (0.8–1.5) | 1.1 (0.8–1.6) | 1.1 (0.8–1.7) | .02 |
| Transplant | |||||
| Donation after cardiac death | 346 (4.5%) | 34 (2.2%) | 5 (2.1%) | 26 (1.8%) | <.01 |
| Partial/split liver | 123 (1.6%) | 21 (1.3%) | 5 (2.1%) | 40 (2.8%) | <.01 |
| Mean cold ischemia time, h (SD) | 7.8 (3.6) | 7.6 (3.9) | 7.7 (3.5) | 7.5 (3.4) | <.01 |
| Regional share | 1643 (21.5%) | 300 (19.0%) | 46 (18.9%) | 308 (21.7%) | .12 |
| National share | 532 (7.0%) | 140 (8.9%) | 18 (7.4%) | 34 (2.4%) | <.01 |
SD, standard deviation; IQR, interquartile range.